Joel Crater is a dynamic leader with a proven track record of success in the medical device and biotechnology industries. With a career spanning over twenty years, Joel has consistently demonstrated his expertise in commercialization, business development, and international expansion. He currently serves as Vice President of Business Development for MedAlliance, developing a novel DCB utilizing sirolimus to treat coronary and peripheral disease. Prior to that, Joel served as the Vice President of North America for Concept Medical and Director of Corporate Accounts at Phillips, where he played a pivotal role in driving business growth and establishing strategic partnerships. Before that, he held key leadership positions at US Endovascular, IDEV Medical Technologies, Inc, Foxhollow Technologies, Perclose, and Scios.
Joel has prepared markets for new technologies and spearheaded successful product launches throughout his career. His ability to identify emerging trends and his strategic vision have consistently enabled him to introduce innovative solutions that address critical healthcare needs. Joel has utilized his deep industry knowledge to scale infrastructure and drive revenue growth. His passion for advancing healthcare technologies and commitment to improving patient outcomes make him a sought-after thought leader, and his contributions to the medical device and biotechnology sectors have been recognized through numerous accolades and industry awards.
The background described above reflects this individual’s professional experience, including prior roles, outside activities, and involvement with Cultivation Capital portfolio companies. It does not represent the investment performance of any Cultivation Capital fund and should not be relied upon as an indication of future results.
